Acid suppression therapy in critically ill patients significantly reduces the incidence of stress ulceration and gastrointestinal (GI) bleeding; however, recent studies suggest that proton pump inhibitors (PPIs) increase the risk of pneumonia. We wanted to test the hypothesis that acid suppressive therapy promotes alteration in the bacterial flora in the GI tract and leads to colonization of the upper airway tract with pathogenic species, potentially forming the biological basis for the observed increased incidence of pneumonia in these patients. This was a prospective observational study on patients (adults 18 years or older) admitted to the medical intensive care unit (MICU) at a tertiary care centre. Exclusion criteria included all patients with a diagnosis of pneumonia at admission, with infection in the upper airway, or with a history of significant dysphagia. Oropharyngeal cultures were obtained on day 1 and days 3 or 4 of admission. We collected data on demographics, clinical information, and severity of the underlying disease using APACHE II scores. There were 110 patients enrolled in the study. The mean age was 49±16 years, 50 were women, and the mean APACHE II score was 9.8±6.5. Twenty per cent of the patients had used a PPI in the month preceding admission. The first oropharyngeal specimen was available in 110 cases; a second specimen at 72-96 h was available in 68 cases. Seventy-five per cent of the patients admitted to the MICU had abnormal flora. In multivariate logistic regression, diabetes mellitus and PPI use were associated with abnormal oral flora on admission. Chronic renal failure and a higher body mass index reduced the frequency of abnormal oral flora on admission. Most critically ill patients admitted to our MICU have abnormal oral flora. Patients with diabetes and a history of recent PPI use are more likely to have abnormal oral flora on admission.
INTRODUCTION
The human microbiota has a crucial role in both health and disease. Bacterial populations vary in composition and in density according to the body region. In addition, these populations undergo dynamic changes secondary to changes in host defences and to exposure to exogenous agents, such as antibiotics. Hospitalized patients are at increased risk of infection for multiple reasons, and changes in flora contribute to this risk. For example, the oral microbial flora of critically ill patients changes from a streptococcal predominance to a Gram-negative predominance (Abele-Horn et al., 1997; Johanson et al., 1988) . Since oral bacteria frequently cause nosocomial pneumonia, the acquisition of more virulent organisms may increase the risk of infection, which in turn increases morbidity, mortality, costs and length of hospital stay (Fagon et al., 1993; Rello et al., 2002; Tablan et al., 2004) .
Medical therapy with gastric acid suppression drugs could increase the risk of nosocomial infection. Several possibilities could explain the risk of pneumonia associated with proton pump inhibitors (PPIs). It has been suggested that the increased bacterial colonization of the stomach observed in PPI users may be associated with pulmonary micro-aspiration and lung colonization (Theisen et al., 2000; Väkeväinen et al., 2000) . Mikawa et al. (1999) demonstrated that PPIs impair neutrophil function and natural killer cell activity by decreasing extracellular and intracellular oxygen intermediate production, and, therefore, potentially decrease host defences. However, there is limited information about the effect of PPIs on oral microbial flora in critically ill patients. We performed this study to (1) determine the oral flora of the critically ill patients at the time of admission and 3 days after admission to the intensive care unit (ICU), and (2) to determine whether patient characteristics or PPI use had an effect on the presence of abnormal oral flora.
METHODS
Patients. This prospective observational study was conducted from December 2009 to September 2010 in the medical ICU (MICU) of University Medical Center, a 411-bed tertiary care hospital in Lubbock, Texas. The MICU has 30 beds with annualized census ranging from 1300 to 1800 patients. All critically ill patients admitted to the Internal Medicine faculty were considered eligible for the study. Exclusion criteria included all patients with a diagnosis of pneumonia at admission, with an upper airway infection, or with a history of significant dysphagia. One hundred and ten patients were included. Patient demographics, clinical information and APACHE II scores were recorded on admission. Oropharyngeal swabs were taken from the oropharynx behind the posterior tonsillar pillar on day 1 and days 3 to 4 after admission. This study was approved by the Institutional Review Board at Texas Tech University Health Sciences Center, and patients gave written and informed consent.
Microbiological procedures. Oropharyngeal swabs were processed within 2 h after collection and were emulsified (with any purulent material present on the swab) in 1 ml tryptic soy broth. One hundred microlitre aliquots were plated to tryptic soy agar with 5 % sheep blood (blood agar) and chocolate agar with isovitalex (Becton Dickinson) and streaked in four quadrants for semiquantitation of growth. Both plates were incubated in 5 % CO 2 at 35 uC for 18-24 h. All representative colonial morphotypes were semiquantitated (from scarce to 4+) and Normal vs abnormal flora Abnormal flora in first specimen 51 (75 %) Abnormal flora in second specimen 51 (75 %) Normal flora in first and second specimens 9 (13.2 %) Abnormal flora in first and second specimens 43 (63.2 %) Normal flora in first and abnormal flora in second specimen 8 (11.8 %) Abnormal flora in first and normal flora in second specimen 8 (11.8 %) Presence or absence of pneumonia-causing organisms Pneumonia-causing organisms in first specimen 44 (64.7 %) Pneumonia-causing organisms in second specimen 46 (67.6 %) Pneumonia-causing organisms absent in first and second specimens 12 (17.6 %) Pneumonia-causing organisms present in first and second specimens 34 (50.0 %) Pneumonia-causing organisms present in first specimen only 10 (14.7 %) Pneumonia-causing organisms present in second specimen only 12 (17.6 %) Presence or absence of indicator organisms Indicator organisms in first specimen 31 (45.6 %) Indicator organisms in second specimen 34 (50.0 %) Indicator organisms absent in first and second specimens 26 (38.2 %) Indicator organisms present in first and second specimens 23 (33.8 %) Indicator organisms present in first specimen only 8 (11.8 %) Indicator organisms present in second specimen only 11 (16.2 %) Definitions. We classified specimens with at least four species of bacteria usually found in the oral cavity and growth of 3+ or 4+ as Table 5 . Overall interpretation of the flora present in first vs second specimens for 68 patients vs whether or not they received PPIs
Percentages reflect the proportion of patients who did or did not receive PPIs having the described flora. 
PPI received

RESULTS
There were 110 patients (45 % were women) with a mean age of 49±16 years and a mean APACHE II score of 9.8±6.5. Fifty per cent of the subjects were non-Hispanic Caucasians, 40 % were Hispanics, and 10 % were African Americans. Twenty per cent of the patients had used a PPI in the month preceding admission. The first oropharyngeal specimen was available from all 110 patients; a second oropharyngeal specimen was available from 68 patients (62 %).
The bacterial distribution in the first and second sample is shown in Table 1 . Some micro-organisms were more frequent in the second sample than the first sample, including Actinomyces spp., Candida albicans, coagulase-negative Staphylococcus NOS both oxacillin sensitive and resistant, Klebsiella pneumoniae, Streptococcus dysgalactiae and Streptococcus pneumoniae.
Abnormal flora was present in 75 % of the patients in both first and second specimens (Table 2) . In univariate analysis, a higher body mass index (BMI) and chronic kidney disease appeared to reduce the frequency of abnormal flora (Table 3 ). In the multivariable logistic regression, the following variables were independently associated with the presence of abnormal flora on admission: PPI use before admission (OR, 5.56; 95 % CI, 1. were risk factors for abnormal flora on the second specimen. Additional analysis of both groups showed that 11.8 % of patients had normal flora on the first sample and abnormal flora on the second specimen (Table 2) . Fortyfour patients (64.7 %) had a pneumonia-causing organism in the first specimen, and 46 patients (67.6 %) had one in the second specimen. Some patients (17.6 %) had a pneumonia-causing isolate in the second sample only.
Additional analysis of the first sample showed that 65.5 % of patients on acid suppressive therapy had pneumonia-causing organisms compared to 61.5 % in patients not on acid suppressive therapy (P50.79) ( Table 4 ). These numbers were 67.3 % vs 69.2 % for the second sample (P50.89). The presence of indicator organisms was similar in patients on acid suppressive therapy and in patients not on acid suppressive therapy in both the first and second specimens (Table 5) .
DISCUSSION
This study demonstrates that patients admitted to an ICU frequently have abnormal flora in their upper respiratory tract and that diabetes and PPI use predict the presence of abnormal flora. Patients with a higher BMI and chronic renal failure were less likely to have abnormal flora; the explanation for these two associations requires more study. In addition, these patients frequently had pneumoniacausing bacteria in their oropharyngeal secretions. The flora in the upper airway has dynamic characteristics and is frequently abnormal in acutely ill patients. These changes may form the basis for the development of infection during hospitalization in ICUs.
In this study, patients on PPIs were more likely to have abnormal oral flora after controlling for other confounding variables. Recent studies suggest that PPIs alter the normal host flora. Wang et al. collected gastric fluid during routine endoscopy in patients on PPIs, on H2-receptor blockers and on no acid suppression therapy. The mean pH values were 5.11, 4.12 and 2.91, respectively. Bacterial cultures were positive in 67 %, 46 % and 29 %, respectively. These results demonstrate the potential effects of PPIs on gastric bacterial infection. Several studies have suggested that PPI use increases the risk of community-acquired pneumonia (Gulmez et al., 2007; Laheij et al., 2004; Myles et al., 2009; Sarkar et al., 2008) and ventilator-associated pneumonia (Prod'hom et al., 1994) . In a meta-analysis of 31 studies, Eom et al. (2011) reported that use of PPIs increased the likelihood of pneumonia 1.27-fold. It is assumed that increased gastric pH following PPI use facilitates bacterial growth, and pneumonia is caused through the gastropulmonary route. However, Bonten et al. (1995) suggested otherwise. In their study a higher pH in the stomach was associated with higher gastric colonization but did not influence colonization of the upper respiratory tract or the incidence of ventilator-associated pneumonia. These authors concluded that gastric bacteria are unlikely causes of ventilator-associated pneumonias.
PPIs inhibit the H + /K + -ATPase pump in the stomach and other tissue. Altman and colleagues have demonstrated the presence of this pump in laryngeal seromucinous glands (Altman et al., 2005) and lung mucus glands (Altman et al., 2007) . In addition, there is evidence that systemic medication may enter saliva through diffusion (Baker, 2006; Robinson, 2004) . Thus, it is possible for the pH of the seromucinous secretions to be affected by PPI use, and this could alter the bacteria growth environment in the oropharynx. Although patients with PPI use in our study were more likely to have an abnormal oral flora, the number of pneumonia-causing organisms in the oropharynx was not significantly different between these patients and those who were not on PPIs.
Patients with diabetes were also more likely to have abnormal oral flora in our study. There are many possible mechanisms for this observation, including xerostomia, hyposalivation and more acidotic oral pH in these patients (Selimoglu et al., 1999) . Khovidhunkit et al. (2009) studied 154 patients with diabetes and 50 healthy controls and reported that patients with hyposalivation were more likely to have higher numbers of Streptococcus mutans, Lactobacillus spp. and Candida spp. compared to patients without hyposalivation. Conversely, Pinducciu et al. (1996) found that there was no substantial difference in the oral anaerobic and aerobic microbial flora of patients with wellcontrolled type 1 diabetes compared to a healthy control group.
Patients with chronic renal failure (CRF) were less likely to have an abnormal oral flora in our study. Al-Nowaiser et al. (2003) conducted a study on 70 children with CRF and found that numbers of oral Streptococcus mutans and Candida albicans were significantly lower in patients with CRF compared to the healthy control group. The pH of the saliva of CRF patients was significantly higher than in the control group. The authors concluded that higher salivary urea concentration and buffering capacity of the patients with CRF may inhibit Streptococcus mutans growth in these patients. However, other bacteria such as Streptococcus mitis and Streptococcus parasanguinis were found more frequently in patients with CRF in this study.
Our study has some limitations. Second specimens on days 3 to 4 were not available for some patients. This was inevitable due to early discharge of those patients. Second, we took only one sample on each day and may have missed some bacterial species because of differences in distribution in the oropharynx. Our study does demonstrate that many patients admitted to the ICU have abnormal oral flora and that patients with diabetes mellitus and a history of recent PPI use are more likely to have abnormal flora. Other factors, such as chronically poor health (e.g. nursing home status), recent prolonged severe hospitalization, and possibly recent courses of antibiotics, likely influence oral flora populations but were not evaluated in this study. The number of patients with abnormal flora, pneumoniacausing organisms or indicator organisms was similar in the first sample and the second sample. This suggests that changes in flora occur before hospitalization. This information is potentially useful to identify patients who may be at greater risk of pneumonia.
